Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > @TOTALDESTRUCTION
View:
Post by elgin1 on Jan 25, 2021 5:43pm

@TOTALDESTRUCTION

Tc,

Not sure where your getting your info from. Orphan Drug status by Fda will be approved after another 23 patients for Hypoglycemic diabetics. That will be less than 2 years imo  .... not Type 1 Diabetes... that will take a few years with multicenter study and much larger patient pool.

They also have indications for Hemophilia and Thyroid and possibly a few others not mentioned yet.

There were 3 sets of warrants to be exercised . They will be done by end of the week. Weak hands are gone, some longterm shareholders from 5 cent placement cashed out . You can't blame them for waiting more than 10 years.

It's going to take a pharma collaboration that involves equity stake and this will be a double from here.  Conparabkes are valued at $1 Billion US with no clinical Fda trials . 


it does not matter what you say Totalcorruption because the share price will be determined by the market .... will be at much higher valuations.

Just hope you did not short it .

Elgin

Comment by TotalCorruption on Jan 25, 2021 5:45pm
So as I said 1-4 years. Glad we agree
Comment by BioTeck on Jan 25, 2021 5:52pm
Hey deadbeat, the paper holder can be sold for a billion alone. We don't need anti-rejection. THere are plenty of companies out there with cells who need said paper holder. Clearly you are butthurt that you got left at the station. There is still standing room in the econmy section for you and your buddy total corruption.The time to play this game has past, goodluck.
Comment by Redbaron2211 on Jan 25, 2021 6:04pm
Another one to lisnten to Elgin.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities